4 research outputs found
An Oral Recombinant Vaccine in Dogs against Echinococcus granulosus, the Causative Agent of Human Hydatid Disease: A Pilot Study
Dogs are the main source of human cystic echinococcosis. An oral vaccine would be an important contribution to control programs in endemic countries. We conducted two parallel experimental trials in Morocco and Tunisia of a new oral vaccine candidate against Echinococcus granulosus in 28 dogs. The vaccine was prepared using two recombinant proteins from adult worms, a tropomyosin (EgTrp) and a fibrillar protein similar to paramyosin (EgA31), cloned and expressed in a live attenuated strain of Salmonella enterica serovar typhimurium
Polymers in Ophthalmology
El articulo Polymers in ophthalmology es parte del capitulo 6 del libro Advanced polymers in medicine.Ophthalmological sciences are disciplines focused in the health of the eyes and related structures, as well as vision, visual systems, and vision information processing in humans; dealing with the anatomy, physiology and diseases of the eye. Along time a wide variety of materials, including metals, ceramics and polymers, have been developed and used in different ophthalmic applications. Although, modern ophthalmic devices and drug platforms are made with polymeric materials. Applications of polymers in ophthalmology include vitreous replacement fluids, contact lenses, intraocular lenses, artificial orbital walls, artificial corneas, artificial lacrimal ducts, glaucoma drainage devices, viscoelastic replacements, drug delivery systems, sclera buckles, retinal tacks and adhesives, and ocular endotamponades. Both synthetic and natural polymeric biomaterials are used in ophthalmological applications, although in the lasts years most efforts were focused in natural and biocompatible materials, such as gelatin, hyaluronan, chitosan, gums, etc.; developing, tablets, films, suspensions, nanosystems, inserts, etc. This chapter attempts to offers an insight into the importance of polymers in the design and development of pharmaceuticals platforms used in ocular therapeutics.Fil: Calles, Javier Adrián. Universidad Nacional del Sur. Planta Piloto de IngenierĂa QuĂmica; Argentina.Fil: Bermudez, JosĂ© MarĂa. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas. Centro CientĂfico TecnolĂłgico Conicet - Salta. Instituto de Investigaciones para la Industria QuĂmica; Argentina.Fil: Bermudez, JosĂ© MarĂa. Universidad Nacional de Salta. Facultad de IngenierĂa. Instituto de Investigaciones para la Industria QuĂmica; Argentina.Fil: Valles, Enrique Marcelo. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas. Centro CientĂfico TecnolĂłgico Conicet BahĂa Blanca; Argentina.Fil: Valles, Enrique Marcelo. Universidad Nacional del Sur. Planta Piloto de IngenierĂa QuĂmica; ArgentinaFil: Allemandi, Daniel Alberto. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas. Centro CientĂfico TecnolĂłgico Conicet - CĂłrdoba; Argentina.Fil: Allemandi, Daniel Alberto. Universidad Nacional de CĂłrdoba. Facultad de Ciencias QuĂmicas. Unidad de InvestigaciĂłn y Desarrollo en TecnologĂa FarmacĂ©utica; Argentina.Fil: Palma, Santiago Daniel. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas. Centro CientĂfico TecnolĂłgico Conicet - CĂłrdoba; Argentina.Fil: Palma, Santiago Daniel. Universidad Nacional de CĂłrdoba. Facultad de Ciencias QuĂmicas. Unidad de InvestigaciĂłn y Desarrollo en TecnologĂa FarmacĂ©utica; Argentina.Otras Ciencias QuĂmica